In current study, we observed a significant positive correlation between plasma CRP levels and the occurrence of tumor, but we failed to demonstrate a statistically significant difference in CRP levels between ovarian cancer patients with early stage and late stage, while CRP levels tended to be higher in patients with advanced cancer patients. This evidence concerns the gene CRP and neoplasm.